Is a complete INO research report available?

No complete published report is available for Inovio Pharmaceuticals, Inc. (INO) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

Inovio Pharmaceuticals, Inc. (INO)

NASDAQ: INO · USD

$0.93

+0.04 (+4.5%)· Recorded snapshot

Market cap	96.2M
Net income (ttm)	-67.4M
EPS (ttm)	-$1.03
Shares out	103.4M
Volume	4,436,540
Beta	1.61

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Net income (ttm): -67.4M
EPS (ttm): -$1.03
Market cap: 96.2M

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
EXAS	Exact Sciences Corp	—	—	—	—	—	—	نگه‌داری

Metric	Value
Amount currency	USD
CIK code	0001055726
Company name	Inovio Pharmaceuticals, Inc.
Country	United States
Country code	US
CUSIP number	45773H409
Earnings date	2026-11-09
Earnings time	amc
Employees	112
Employees change	-22
Employees growth	-16.42%
Enterprise value	$67.5M
Exchange	NASDAQ
Financial currency	USD
Financial report date	2026-06-30
First seen	2026-05-09
Fiscal year end	December
Founded	1979
Industry	Biotechnology
IPO date	1998-02-12
Is primary listing	Yes
Is SPAC	No
ISIN number	US45773H4092
Last 10-K release date	2026-03-12
Last earnings date	2026-08-12
Last refreshed	2026-10-28
Last stock split date	2024-01-25
Last stock split type	Reverse
Market cap	$96.2M
Market cap category	Micro-Cap
Next earnings date	2026-11-09
Options	Yes
Price	$0.93
Price currency	USD
Sector	Healthcare
SIC code	2834
Stock price date	2026-10-28
Symbol	INO
U.S. state	Pennsylvania
Website	https://www.inovio.com

Metric

Value

Amount currency

USD

CIK code

0001055726

Company name

Inovio Pharmaceuticals, Inc.

Country

United States

Country code

CUSIP number

45773H409

Earnings date

2026-11-09

Earnings time

amc

Employees

112

Employees change

-22

Employees growth

-16.42%

Enterprise value

$67.5M

Exchange

NASDAQ

Financial currency

USD

Financial report date

2026-06-30

First seen

2026-05-09

Fiscal year end

December

Founded

1979

Industry

Biotechnology

IPO date

1998-02-12

Is primary listing

Yes

Is SPAC

ISIN number

US45773H4092

Last 10-K release date

2026-03-12

Last earnings date

2026-08-12

Last refreshed

2026-10-28

Last stock split date

2024-01-25

Last stock split type

Reverse

Market cap

$96.2M

Market cap category

Micro-Cap

Next earnings date

2026-11-09

Options

Yes

Price

$0.93

Price currency

USD

Sector

Healthcare

SIC code

2834

Stock price date

2026-10-28

Symbol

INO

U.S. state

Pennsylvania

Website

https://www.inovio.com

Metric	Value
Earnings yield	-111.16%
FCF / EV yield	-118.17%
FCF yield	-83.25%
Forward EV/Sales	3.16x
Forward P/S	4.48x
P/B ratio	16.77x
Price / tangible book value	22.2x
Sector forward P/E	23.56x
Sector P/E	50.08x

Metric

Value

Earnings yield

-111.16%

FCF / EV yield

-118.17%

FCF yield

-83.25%

Forward EV/Sales

3.16x

Forward P/S

4.48x

P/B ratio

16.77x

Price / tangible book value

22.2x

Sector forward P/E

23.56x

Sector P/E

50.08x

Metric	Value
Profit per employee	$-602,027
ROA	-84.23%
ROA (5Y)	-42.34%
ROCE	-836.58%
ROE	-409.87%
ROE (5Y)	-107.79%
ROIC	-192.15%

Metric

Value

Profit per employee

$-602,027

ROA

-84.23%

ROA (5Y)

-42.34%

ROCE

-836.58%

ROE

-409.87%

ROE (5Y)

-107.79%

ROIC

-192.15%

Metric	Value
EPS growth quarters	16
EPS growth years	4
Net income growth quarters	3
Net income growth years	4
Revenue growth	-69.99%
Revenue growth years	0

Metric

Value

EPS growth quarters

EPS growth years

Net income growth quarters

Net income growth years

Revenue growth

-69.99%

Revenue growth years

Metric	Value
Capital expenditures	$-195,395
Depreciation and amortization	$1.3M
EBIT	$-79.3M
EBITDA	$-77.9M
EPS	$-1.03
FCF per share	$-0.78
Financing cash flow	$70.2M
Free cash flow	$-80.8M
Free cash flow minus SBC	$-83.8M
Gross profit	$-48.5M
Investing cash flow	$17.6M
Net cash flow	$7.2M
Net income	$-67.4M
Operating cash flow minus SBC	$-83.6M
Operating income	$-79.3M
Stock-based compensation	$3M

Metric

Value

Capital expenditures

$-195,395

Depreciation and amortization

$1.3M

EBIT

$-79.3M

EBITDA

$-77.9M

EPS

$-1.03

FCF per share

$-0.78

Financing cash flow

$70.2M

Free cash flow

$-80.8M

Free cash flow minus SBC

$-83.8M

Gross profit

$-48.5M

Investing cash flow

$17.6M

Net cash flow

$7.2M

Net income

$-67.4M

Operating cash flow minus SBC

$-83.6M

Operating income

$-79.3M

Stock-based compensation

$3M

Metric	Value
Altman Z-Score	-56
Book value per share	$0.05
Debt / equity	1.83
Long-term assets	$9.5M
Long-term liabilities	$5.1M
Net cash (debt)	$28.7M
Net cash / market cap	29.55%
Net cash growth	-22.28%
Net debt / equity	-6.56
Piotroski F-Score	0
Property, plant and equipment	$7.6M
Shareholders' equity	$4.4M
Tangible book value	$4.4M
Tangible book value per share	$0.05
Total assets	$49.4M
Total cash	$36.7M
Total debt	$8M
Total liabilities	$45M
WACC	12.11%

Metric

Value

Altman Z-Score

-56

Book value per share

$0.05

Debt / equity

1.83

Long-term assets

$9.5M

Long-term liabilities

$5.1M

Net cash (debt)

$28.7M

Net cash / market cap

29.55%

Net cash growth

-22.28%

Net debt / equity

-6.56

Piotroski F-Score

Property, plant and equipment

$7.6M

Shareholders' equity

$4.4M

Tangible book value

$4.4M

Tangible book value per share

$0.05

Total assets

$49.4M

Total cash

$36.7M

Total debt

$8M

Total liabilities

$45M

WACC

12.11%

Metric	Value
Current assets	$39.9M
Current liabilities	$39.9M
Current ratio	1
Net working capital	$-33.8M
Quick ratio	0.92
Working capital	$-1,810

Metric

Value

Current assets

$39.9M

Current liabilities

$39.9M

Current ratio

Net working capital

$-33.8M

Quick ratio

0.92

Working capital

$-1,810

Metric	Value
Buyback yield / dilution	-92.4%
Dividend yield	0%
Shareholder yield	-92.4%

Metric

Value

Buyback yield / dilution

-92.4%

Dividend yield

Shareholder yield

-92.4%

Metric	Value
10Y price change	-98.77%
10Y return CAGR	-35.6%
10Y total return	-98.77%
150-day SMA	$1.15
15Y price change	-97%
15Y return CAGR	-20.84%
15Y total return	-97%
1D price change	4.49%
1M price change	-19.98%
1M total return	-19.98%
1W price change	-6.51%
1W total return	-6.51%
1Y price change	-62.08%
1Y return CAGR	-62.11%
1Y total return	-62.08%
20-day SMA	$1.02
200-day SMA	$1.27
20Y price change	-99.38%
20Y return CAGR	-22.46%
20Y total return	-99.38%
3M price change	-2.17%
3M total return	-2.17%
3Y price change	-78.58%
3Y return CAGR	-40.16%
3Y total return	-78.58%
50-day SMA	$1.16
50-day SMA vs 200-day SMA	50under200
52-week high	$2.72
52-week high date	2025-12-17
52-week low	$0.56
52-week low date	2026-07-30
5Y price change	-98.84%
5Y return CAGR	-59%
5Y total return	-98.84%
6M price change	-19.3%
6M total return	-19.3%
All-time high	$2,352.00
All-time high date	2000-03-06
All-time low	$0.56
All-time low date	2026-07-30
Average true range (ATR)	$0.10
Average volume	4M
Beta (1Y)	1.95
Beta (2Y)	1.48
Beta (5Y)	1.61
Change from 52-week high	-65.81%
Change from 52-week low	65.13%
Change from all-time high	-99.96%
Change from all-time low	67.65%
Change from open	0.97%
Day's gap	3.49%
Dollar volume	$4.1M
High price	$0.98
Low price	$0.92
Monthly RSI	36.45
Open price	$0.92
Position in 52-week range	15.52%
Premarket change	5.25%
Premarket close	$0.89
Premarket price	$0.94
Premarket volume	118.4K
Previous close	$0.89
Price vs 150-day SMA	-17.61%
Price vs 20-day SMA	-7.43%
Price vs 200-day SMA	-25.83%
Price vs 50-day SMA	-18.74%
Relative volume	1.1
RSI	43.34
Sharpe ratio	-0.62
Sharpe ratio (3Y)	-0.2
Sharpe ratio (5Y)	-0.6
Sortino ratio	-0.72
Sortino ratio (3Y)	-0.22
Sortino ratio (5Y)	-0.78
Volume	4.4M
Weekly RSI	41.01
YTD price change	-45.74%
YTD total return	-45.74%

Metric

Value

10Y price change

-98.77%

10Y return CAGR

-35.6%

10Y total return

-98.77%

150-day SMA

$1.15

15Y price change

-97%

15Y return CAGR

-20.84%

15Y total return

-97%

1D price change

4.49%

1M price change

-19.98%

1M total return

-19.98%

1W price change

-6.51%

1W total return

-6.51%

1Y price change

-62.08%

1Y return CAGR

-62.11%

1Y total return

-62.08%

20-day SMA

$1.02

200-day SMA

$1.27

20Y price change

-99.38%

20Y return CAGR

-22.46%

20Y total return

-99.38%

3M price change

-2.17%

3M total return

-2.17%

3Y price change

-78.58%

3Y return CAGR

-40.16%

3Y total return

-78.58%

50-day SMA

$1.16

50-day SMA vs 200-day SMA

50under200

52-week high

$2.72

52-week high date

2025-12-17

52-week low

$0.56

52-week low date

2026-07-30

5Y price change

-98.84%

5Y return CAGR

-59%

5Y total return

-98.84%

6M price change

-19.3%

6M total return

-19.3%

All-time high

$2,352.00

All-time high date

2000-03-06

All-time low

$0.56

All-time low date

2026-07-30

Average true range (ATR)

$0.10

Average volume

Beta (1Y)

1.95

Beta (2Y)

1.48

Beta (5Y)

1.61

Change from 52-week high

-65.81%

Change from 52-week low

65.13%

Change from all-time high

-99.96%

Change from all-time low

67.65%

Change from open

0.97%

Day's gap

3.49%

Dollar volume

$4.1M

High price

$0.98

Low price

$0.92

Monthly RSI

36.45

Open price

$0.92

Position in 52-week range

15.52%

Premarket change

5.25%

Premarket close

$0.89

Premarket price

$0.94

Premarket volume

118.4K

Previous close

$0.89

Price vs 150-day SMA

-17.61%

Price vs 20-day SMA

-7.43%

Price vs 200-day SMA

-25.83%

Price vs 50-day SMA

-18.74%

Relative volume

1.1

RSI

43.34

Sharpe ratio

-0.62

Sharpe ratio (3Y)

-0.2

Sharpe ratio (5Y)

-0.6

Sortino ratio

-0.72

Sortino ratio (3Y)

-0.22

Sortino ratio (5Y)

-0.78

Volume

4.4M

Weekly RSI

41.01

YTD price change

-45.74%

YTD total return

-45.74%

Metric	Value
Float	95.8M
Float percentage	92.64%
Shares change (QoQ)	18.11%
Shares change (YoY)	92.4%
Shares held by insiders	0.38%
Shares held by institutions	31.96%
Shares outstanding	103.4M
Short % of float	22.24%
Short % of shares	20.6%
Short ratio	6.9 days

Metric

Value

Float

95.8M

Float percentage

92.64%

Shares change (QoQ)

18.11%

Shares change (YoY)

92.4%

Shares held by insiders

0.38%

Shares held by institutions

31.96%

Shares outstanding

103.4M

Short % of float

22.24%

Short % of shares

20.6%

Short ratio

6.9 days

Inovio Pharmaceuticals, Inc. (INO)

Price

Financial snapshot

Fair-value bridge

Latest news · INO

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All INO indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on INO

Frequently asked questions